ANATOMY 1 Name of the Department: Department ... - Biomeedikum

More documents

Recommendations

Info

SECTION I: APPENDIXES 54. C.Löfberg, J.Harro, V.Matto, L.Oreland. Cholecystokinin peptides and receptor binding in rat brain after DSP-4 treatment. Neuropeptides, 1998, vol. 32, No 2, pp. 103-108. 55. T.Marandi, V.Vasar, L.Rägo. The pattern of use of antidepressants in Estonia in 1996. Nord Psykiatr Tidsskr, 1998, vol. 52, No 6, pp. 465-473. 56. V.Matto, L.Allikmets. Rat exploratory behaviour after acute or repeated antidepressant treatment in open-field and exploration-box tests. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 145-157. 57. V.Matto, L.Allikmets. Rapid changes in the affinity of the 5-hydroxytryptamine transporter binding sites in rat frontal cortex after single citalopram injection. Pharmaceutical and Pharmacological Letters, 1998, vol. 8, No 4, pp. 90-92. 58. V.Matto, L.Allikmets. Comparison of rat exploratory behaviour after noradrenergic denervation in elevated zero-maze and open tests. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 16-19. 59. V.Matto, L.Allikmets. Apomorphine-induced aggressive and nonaggressive rats differ in [ 3 H]raclopride-sensitive D2 receptor binding characteristics. Medical Science Research, 1998, vol. 26, pp. 499-501. 60. V.Matto, L.Allikmets, T.Skrebuhhova. Apomorphine-induced aggressiveness and [ 3 H]citalopram binding after antidepressant treatment in rats. Pharmacol. Biochem. Behav., 1998, vol. 59, No 3, pp. 747-752. 61. V.Matto, T.Skrebuhhova, L.Allikmets. The effect of antidepressants on rat aggressive behavior in the electric footshock and apomorphine-induced aggressiveness paradigms. Meth. Find. Exp. Clin. Pharmacol., 1998, vol. 20, No 4, pp. 329-337. 62. M.J.Otter, L.H.Alllikmets, A.M.Zharkovsky, L.G.Polevoi. Neurobutaal (kaltsiumoksübutüraat) - uus nootroopne preparaat. II. Biosaadavus ja toimed kestval manustamisel. Nootroopsed preparaadid. Moskva, 1998, lk. 149-158 (vene keeles). 63. P.Pokk, A.Zharkovsky. The effect of buspirone on the behaviour of control and stressed mice. J. of Physiol. Pharmacol., 1998, vol. 49, No 1, pp. 175-186. 64. P.Pokk, A.Zharkovsky. Small platform stress attenuates the anxiogenic effect of diazepam withdrawal in the plus-maze test. Behavioural Brain Rssearch, 1998, vol. 98, pp. 153-157. 65. R.Pähkla, M.Zilmer, T.Kullisaar, L.Rägo. Comparison of the antioxidant activity of melatonin and pinoline in vitro. J. Pineal Res., 1998, vol. 24, pp. 96-101. 66. L.Rägo. An update of regulatory affairs in Estonia. NLN Baltic Conference 1998. Clinical Trials of Medicines - Opportunities and Challenges in the Baltic Region. June 15-16, 1998, Vilnius Lithuania. NLN Publication No 49. Nordic Council on Medicines, Uppsala, 1998, pp. 19-24. 67. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. Modified method for the induction of ethanol dependence in mice. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 89-92. 68. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. Nitric oxide synthase inhibitor 7-nitroindazole attenuates the behavioural signs of ethanol withdrawal due to pharmacokinetic interaction. Med. Sci. Res., 1998, vol. 26, pp. 821-822. 69. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. The effect of the nitric oxide synthase inhibitor 7-nitroindazole on ethanol pharmacokinetics in rats after acute and chronic ethanol administration. Alcohol & Alcoholism, 1998, vol. 33, No 6, pp. 609-615. 70. E.De Sousa, V.Veksler, A.Minajeva, A.Kaasik, P.Mateo, E.Mayoux, J.Hoerter, X.Bigard, B.Serrurier, R.Ventura-Clapier. Subcellular creatine kinase alterations implications in heart failure. Circulation Research, 1999, vol. 85, pp. 68-76. 71. J.Harro, R.Häidkind, M.Harro, A.-R.Modiri, P.-G.Gillberg, R.Pähkla, V.Matto, L.Oreland. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment. Eur. Neuropsychopharm., 1999, vol. 10, pp. 5-16. 72. J.Harro, R.Pähkla, A.-R.Modiri, M.Harro, A.Kask, L.Oreland. Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and β-adrenoceptor binding in the rat. J. Neural. Transm., 1999, vol. 106, pp. 619-629. 73. A.Kaasik, A.Minajeva, E.De Sousa, R. Ventura-Clapier, V.Veksler. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Letters, 1999, vol. 444, pp. 75-77. 74. A.Kaasik, V.Vassiljev, E.Põldoja, A.Kalda, A.Zharkovsky. Do nuclear condensation or fragmentation and DNA fragmentation reflect the mode of neuronal death?. NeuroReport, 1999, vol. 10, No 9, pp. 1937-1942. 75. A.Kalda, A.Kaasik, V.Vassiljev, P.Pokk, A.Zharkovsky. Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Research, 1999, 28246, pp. 1-3. 76. A.Kalda, A.Zharkovsky. Metabotropic glutamate receptor agonists protect from oxygen-glucose deprivation- and colchicines-induced apoptosis in primary cultures of cerebellar granule cells. Neuroscience, 1999, vol. 92, No 1, pp. 7-14. 56
PHARMACOLOGY 77. A.Kask, J.Harro. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y1 receptor antagonist BIBO 3304. Neuropharmacology, 1999, vol. 39, pp. 1-11. 78. A.Kask, T.Kivastik, L.Rägo, J.Harro. Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats. Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 1999, vol. 23, pp. 705-711. 79. A.Kask, R.Pähkla, A.Irs, L.Rägo, J.E. Wikberg, H.B.Schiöth. Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. NeuroReport, 1999, vol. 10, pp. 707-711. 80. V.Matto, T.Skrebuhhova, L.Allikmets. Apomorphine-induced upregulation of serotonin 5-HT2A receptors in male rats is independent from development of aggressive behaviour. J. Physiol. Pharmacol., 1999, vol. 50, No 2, pp. 335-345. 81. V.Matto, L.Allikmets. Rat exploratory behaviour after acute or repeated antidepressant treatment in open-field and exploration-box tests. Baltic J. Lab. Anim. Sci., 1999, vol. 8, pp. 145-147. 82. V.Matto, L.Allikmets. Acute and chronic citalopram treatment differently modulates rat exploratory behaviour in the exploration box test: no evidence for increased anxiety or changes in the [ 3 H]raclopride binding. Pharmacology, 1999, vol. 58, pp. 59-69. 83. V.Matto, L.Allikmets. Apomorphine-induced aggressive and nonaggressive rats differ in [ 3 H]raclopride-sensitive D2 receptor binding characteristics. Medical Science Research, 1999, vol. 26, pp. 499-501. 84. M.Otter. Kuusikymmentä vuotta ensimmäisen Viron farmakopean voimaantulosta. Hippokrates. Suomen Lääketieteen Historian Seuran vuosikirja, 1999, lk. 163-167. 85. M.Otter Sata vuotta huomattavan virolaisen kokullisen farmakologian edustajan Georg Kingiseppin syntymästä. Hippokrates. Suomen Lääketieteen Historian Seuran vuosikirja, 1999, 16 vuosikerta, lk 157-161. 86. T.P.Piepponen, A.Honkanen, T.Kivastik, A.Zharkovsky, A.Turtia, J.A.V.Mikkola, L.Ahtee. Involvement of opioid μ1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission. Pharmacol. Biochem. Behav., 1999, vol. 63, No 2, pp. 245-252. 87. T.P.Piepponen, A.Zharkovsky, T.Kivastik, L.Ahtee. Effects of morphine in rats withdrawn from repeated nifedipine administration. Eur. J. Pharmacol., 1999, vol. 365, pp. 159-164. 88. P.Pokk. The effect of piracetam after repeated elevated plus-maze exposure in rats. Baltic J. Lab. Anim. Sci., 1999, vol. 9, pp. 142-148. 89. R.Pähkla, A.Irs, K.Oselin, L.Rootslane. Digoxin: use pattern in Estonia and bioavailability of the local market leader. J. Clinical Pharm Therap., 1999, vol. 24, pp. 375-380. 90. R.Pähkla, J.Lambert, P.Ansko, P.Winstanley, P.D.O.Davies, R.-A.Kiivet. Comparative bioavailability of three different preparations of rifampicin. J. Clinical Pharm Therap., 1999, vol. 24, pp. 219- 225. 91. R.Rudissaar, K.Pruus, T.Skrebuhhova, L.Allikmets, V.Matto. Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats. Behav. Brain Res., 1999, vol. 106, pp. 91-96. 92. T.Skrebuhhova, L.Allikmets, V.Matto. 5-HT2A receptors in rat brain after acute monoamine depletion. Pharm. Pharmacol. Lett., 1999, vol. 27, pp. 277-280. 93. T.Skrebuhhova, L.Allikmets, V.Matto. Effects of anxiogenic drugs in rat forced swimming test. Methods Findx. Exp. Clin. Pharmacol., 1999, vol. 21, No 3, pp. 173-178. 94. T.Skrebuhhova, L.Allikmets, V.Matto. [ 3 H]ketanseriin binding and elevated plus-maze behaviour after chronic antidepressant treatment in DSP-4 and p-CPA pretreated rats: evidence for partial involvement of 5-HT2A receptors. Methods Findx. Exp. Clin. Pharmacol., 1999, vol. 21, No 7, pp. 483- 490. 95. T.Skrebuhhova-Malmros, L.Allikmets, R.Rudissaar, K.Pruus, V.Matto. Ondansetron fails to reverse antidepressant-elicited antiexploratory effects in the elevated plus-maze anf open field tests. ;edical Science Research, 1999, vol. 27, pp. 835-837. 96. V.Vassiljev, M.Väli, P.Pokk. Effect of nitric oxide synthase inhibitors L-NAME and L-NOARG on behavioural signs of ethanol withdrawal. Med. Sci. Res., 1999, vol 27, pp. 409-410. 97. T.Skrebuhhova-Malmros, K.Pruus, R.Rudissaar, L.Allikmets, V.Matto. Modulation of forced swimming, open field and apomorphine-induced aggressive behaviour by 5-HT2A and 5-HT3 receptor ligands in male Wistar rats. Pharmaceutical and Pharmacological Letters, 1999, vol. 9, No 2, pp. 70-73. 98. M.Väli, V.Vassiljev, I.Drikkit, D.Lepik, A.Kalda, P.Pokk, A.Zharkovsky. Programmed cell death as phenomena in the CNS during ethanol withdrawal. Proceedings of the 3rd Congress of BMLA, Riga (Jurmala), August 19-21, 1998. Medicina Legalis Baltica, 1999, vol. 10, pp. 133-138. 99. A.Zharkovsky, J.Katajamäki, T.Seppälä, L.Ahtee. Morphine-induced analgesia in rats wirhdrawn from concurrent nimodipine and morphine treatment. Pain, 1999, vol. 79, pp. 217-222. 57
Page 1 and 2:
ANATOMY Name of the Department: Dep
Page 3 and 4:
ANATOMY Weaknesses • Limited time
Page 5 and 6: ANATOMY To continue the integration
Page 7 and 8: ANATOMY been reduced from 6 CP to 5
Page 9 and 10: IV. TEACHING RESOURCES ANATOMY 9. I
Page 11 and 12: APPENDIX I-I Visits of the Departme
Page 13 and 14: APPENDIX I-VI Publications of the D
Page 15 and 16: PAPERS IN ESTONIAN JOURNALS ANATOMY
Page 17: APPENDIX I-VII Academic and adminis
Page 20 and 21: SECTION I: APPENDIXES societies: Mo
Page 23 and 24: BIOCHEMISTRY Name of Department: De
Page 25 and 26: BIOCHEMISTRY eliminated. Such alter
Page 27 and 28: BIOCHEMISTRY Biochemistry: resource
Page 29 and 30: APPENDIX I-II BIOCHEMISTRY Postgrad
Page 33 and 34: BIOCHEMISTRY 4. Dementia and Geriat
Page 35 and 36: BIOCHEMISTRY 51. J Cardiovascular r
Page 40 and 41: SECTION I: APPENDIXES ship in acade
Page 42 and 43: SECTION I: SELF-EVALUATION 42 proac
Page 44 and 45: SECTION I: SELF-EVALUATION 44 the a
Page 46 and 47: SECTION I: SELF-EVALUATION 46 The f
Page 48 and 49: SECTION I: SELF-EVALUATION 48 macol
Page 50 and 51: SECTION I: APPENDIXES APPENDIX I-I
Page 52 and 53: SECTION I: APPENDIXES APPENDIX I-IV
Page 54 and 55: SECTION I: APPENDIXES 12. C.Löfber
Page 58 and 59: SECTION I: APPENDIXES 100. Kalda A.
Page 60 and 61: SECTION I: APPENDIXES 12. M. Otter.
Page 66 and 67: SECTION I: APPENDIXES Community 5th
Page 68 and 69: SECTION I: APPENDIXES Tartu as a ph
Page 71 and 72: PHYSIOLOGY Name of Department: Depa
Page 73 and 74: PHYSIOLOGY 3. Describe the strength
Page 75 and 76: PHYSIOLOGY students. According to t
Page 77 and 78: PHYSIOLOGY Physiology: resource eva
Page 79 and 80: PHYSIOLOGY 1999 Kersti Jagomägi, s
Page 83: PHYSIOLOGY 67. J.Kivastik, P.-H.Kin
Page 87 and 88: APPENDIX I-VIII Curriculum Vitae of
Page 89 and 90: PHYSIOLOGY meeting on physiology" 1
Page 91: PHYSIOLOGY University of Kuopio;vis
Page 94 and 95: SECTION I: SELF-EVALUATION ceptual
Page 96 and 97: SECTION I: SELF-EVALUATION 96 stude
Page 98 and 99: SECTION I: SELF-EVALUATION VI. FUTU
Page 100 and 101: SECTION I: APPENDIXES APPENDIX I-I
Page 102 and 103: SECTION I: APPENDIXES APPENDIX I-VI
Page 104 and 105: SECTION I: APPENDIXES 2. Mikelsaar
Page 107:
APPENDIX I-VII Academic and adminis
Page 110 and 111:
SECTION I: APPENDIXES was supported
Page 113 and 114:
PATHOLOGICAL ANATOMY AND FORENSIC M
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
APPENDIX I-I PATHOLOGICAL ANATOMY A
Page 125 and 126:
Page 127:
Page 130 and 131:
SECTION I: APPENDIXES DRIKKIT, ILON
Page 132 and 133:
SECTION I: SELF-EVALUATION 2. How h
Page 134 and 135:
SECTION I: SELF-EVALUATION 8. Is th
Page 136 and 137:
SECTION I: APPENDIXES APPENDIX I-I
Page 138 and 139:
SECTION I: APPENDIXES 1999 Argo Soo
Page 140 and 141:
SECTION I: APPENDIXES APPENDIX I-V
Page 142 and 143:
SECTION I: APPENDIXES 8. Harro J, S
Page 144 and 145:
SECTION I: APPENDIXES 98. Põlluste
Page 147:
Page 150 and 151:
SECTION I: APPENDIXES Nutritional S
Page 152 and 153:
SECTION I: APPENDIXES Economists Cu
Page 154 and 155:
SECTION I: SELF-EVALUATION • Biol
Page 156 and 157:
SECTION I: SELF-EVALUATION 156 The
Page 158 and 159:
SECTION I: SELF-EVALUATION 158 2. C
Page 160 and 161:
SECTION I: SELF-EVALUATION 160 2. T
Page 162 and 163:
SECTION I: SELF-EVALUATION II. EVAL
Page 164 and 165:
SECTION I: SELF-EVALUATION 164 Subj
Page 166 and 167:
Page 168 and 169:
SECTION I: APPENDIXES APPENDIX I-V
Page 170 and 171:
SECTION I: APPENDIXES 31. Waldmann
Page 173:
Page 176 and 177:
SECTION I: APPENDIXES partment of G
Page 178 and 179:
SECTION I: APPENDIXES arum (MSc) in
Page 180 and 181:
SECTION I: SELF-EVALUATION 180 1. T
Page 182 and 183:
SECTION I: SELF-EVALUATION 182 Duri
Page 184 and 185:
SECTION I: SELF-EVALUATION 184 2. B
Page 186 and 187:
Page 188 and 189:
SECTION I: APPENDIXES 19. Tiivel T.
Page 191 and 192:
APPENDIX I-VIII Curriculum Vitae of
Page 193 and 194:
IMMUNOLOGY Name of the Department:
Page 195 and 196:
IMMUNOLOGY equipped with English la
Page 197 and 198:
IMMUNOLOGY Immunology: resource eva
Page 199 and 200:
APPENDIX I-II IMMUNOLOGY Postgradua
Page 201 and 202:
IMMUNOLOGY 19. Juhela S, Hyöty H,
Page 203:
Page 206 and 207:
SECTION I: APPENDIXES Laboratory of
show all

ANATOMY 1 Name of the Department: Department ... - Biomeedikum

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?